What is Neurophos worth?
$310.0Mimplied by the PA Mark · Sep 2026
Neurophos last raised $109.2M in its Later Stage VC (Series A) (Jan 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Neurophos
Create free account
No card required
Valuation timeline
4 marks · Jun 2021 – Sep 2026Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| — | Seed Round | $1.0M | ▮ | ▮ |
| Jan 2026 | Later Stage VC (Series A) | $109.2M | ▮ | ▮ |
| Mar 2024 | Seed Round | $7.2M | ▮ | ▮ |
| Nov 2023 | Accelerator/Incubator | — | ▮ | ▮ |
| Jun 2021 | Seed Round | $1.8M | ▮ | ▮ |
How Neurophos's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Neurophos, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Neurophos worth?
- Neurophos's implied valuation is $310.0M, based on the PA Mark composite price of about $4 per share as of Sep 2026.
- How much has Neurophos raised?
- Neurophos has raised $119.2M in total funding across 5 recorded rounds.
- When did Neurophos last raise?
- Neurophos last raised in Jan 2026 (Later Stage VC (Series A)), raising $109.2M.